| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4738 | 2018 |
| TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis C Quivoron, L Couronné, V Della Valle, CK Lopez, I Plo, O Wagner-Ballon, ... Cancer cell 20 (1), 25-38, 2011 | 1022 | 2011 |
| Integrative analysis identifies four molecular and clinical subsets in uveal melanoma AG Robertson, J Shih, C Yau, EA Gibb, J Oba, KL Mungall, JM Hess, ... Cancer cell 32 (2), 204-220. e15, 2017 | 876 | 2017 |
| Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation T Popova, E Manié, G Rieunier, V Caux-Moncoutier, C Tirapo, T Dubois, ... Cancer research 72 (21), 5454-5462, 2012 | 654 | 2012 |
| Uveal melanoma MJ Jager, CL Shields, CM Cebulla, MH Abdel-Rahman, HE Grossniklaus, ... Nature reviews Disease primers 6 (1), 24, 2020 | 626 | 2020 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 540 | 2021 |
| SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma SJ Furney, M Pedersen, D Gentien, AG Dumont, A Rapinat, L Desjardins, ... Cancer discovery 3 (10), 1122-1129, 2013 | 490 | 2013 |
| Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage S Alsafadi, A Houy, A Battistella, T Popova, M Wassef, E Henry, F Tirode, ... Nature communications 7 (1), 10615, 2016 | 402 | 2016 |
| Oxidative stress promotes myofibroblast differentiation and tumour spreading A Toullec, D Gerald, G Despouy, B Bourachot, M Cardon, S Lefort, ... EMBO molecular medicine 2 (6), 211-230, 2010 | 373 | 2010 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 345 | 2022 |
| Germline BAP1 mutations predispose to renal cell carcinomas T Popova, L Hebert, V Jacquemin, S Gad, V Caux-Moncoutier, ... The American journal of human genetics 92 (6), 974-980, 2013 | 326 | 2013 |
| Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays T Popova, E Manié, D Stoppa-Lyonnet, G Rigaill, E Barillot, MH Stern Genome biology 10, 1-14, 2009 | 304 | 2009 |
| Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types R Lebofsky, C Decraene, V Bernard, M Kamal, A Blin, Q Leroy, TR Frio, ... Molecular oncology 9 (4), 783-790, 2015 | 294 | 2015 |
| Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells B Marty, V Maire, E Gravier, G Rigaill, A Vincent-Salomon, M Kappler, ... Breast Cancer Research 10, 1-15, 2008 | 279 | 2008 |
| Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple-negative breast cancer F Riva, FC Bidard, A Houy, A Saliou, J Madic, A Rampanou, C Hego, ... Clinical chemistry 63 (3), 691-699, 2017 | 251 | 2017 |
| Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers X Peng, Z Chen, F Farshidfar, X Xu, PL Lorenzi, Y Wang, F Cheng, L Tan, ... Cell reports 23 (1), 255-269. e4, 2018 | 248 | 2018 |
| JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas O Mariani, C Brennetot, JM Coindre, N Gruel, C Ganem, O Delattre, ... Cancer cell 11 (4), 361-374, 2007 | 242 | 2007 |
| Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ... JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018 | 233 | 2018 |
| PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers G Gentric, Y Kieffer, V Mieulet, O Goundiam, C Bonneau, F Nemati, ... Cell metabolism 29 (1), 156-173. e10, 2019 | 230 | 2019 |
| Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma FC Bidard, J Madic, P Mariani, S Piperno‐Neumann, A Rampanou, ... International journal of cancer 134 (5), 1207-1213, 2014 | 220 | 2014 |
Olivier LantzInstitut CurieVerified email at curie.fr
